Provided by Tiger Fintech (Singapore) Pte. Ltd.

Infinity Pharmaceuticals, Inc.

0.0160
+0.0000
Volume:- -
Turnover:- -
Market Cap:1.45M
PE:-0.03
High:0.0160
Open:0.0160
Low:0.0160
Close:0.0160
Loading ...
May 11, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Apr 07, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Mar 25, 2020

Major Issues Report

8-K - Current report
Mar 17, 2020

Major Issues Report

Current report, items 5.02, 8.01, and 9.01
Mar 03, 2020

Major Issues Report

8-K - Current report
Mar 03, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 13, 2020

Major Issues Report

Current report, items 2.02, 8.01, and 9.01
Jan 10, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jan 09, 2020

Major Issues Report

Current report, items 1.01, 2.02, 2.03, 3.02, 7.01, and 9.01
Oct 30, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 30, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 16, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Oct 16, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 22, 2019

Major Issues Report

Current report, items 5.02, 8.01, and 9.01
Jul 30, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jul 30, 2019

Major Issues Report

Current report, items 1.01, 2.02, and 9.01
Jun 28, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Jun 14, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 14, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities